NEW Britain General Hospital is a medicare approved dialysis facility center in New Britain, Connecticut and it has 22 dialysis stations. It is located in Hartford county at Dialysis Unit, New Britain, CT, 06050. You can reach out to the office of NEW Britain General Hospital at (860) 224-5195. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. NEW Britain General Hospital has the following ownership type - Non-Profit. It was first certified by medicare in August, 1977. The medicare id for this facility is 070035 and it accepts patients under medicare ESRD program.
| Name | NEW Britain General Hospital |
|---|---|
| Location | Dialysis Unit, New Britain, Connecticut |
| No. of Dialysis Stations | 22 |
| Medicare ID | 070035 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| Dialysis Unit, New Britain, Connecticut, 06050 | |
| (860) 224-5195 | |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
| NPI Number | 1437187291 |
| Doing Business As | New Britain General Hospital |
| Address | 100 Grand St New Britain, Connecticut, 06052 |
| Phone Number | (860) 224-5011 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
| NPI Number | 1508928615 |
| Organization Name | The Hospital Of Central Connecticut |
| Doing Business As | The Hospital Of Central Connecticut At New Britain General And Bradley |
| Address | 100 Grand St New Britain, Connecticut, 06052 |
| Phone Number | (860) 224-5011 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 59 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 8 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 98 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1002 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 14 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 118 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 82 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at NEW Britain General Hospital with elevated calcium levels.
| Patients with hypercalcemia | 111 |
| Hypercalcemia patient months | 1130 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 112 |
| Patients with Serumphosphor less than 3.5 mg/dL | 3 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 16 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 28 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 33 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 78 |
| Patient months included in arterial venous fistula and catheter summaries | 769 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 59 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 97 |
| Hospitalization Rate in facility | 126.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 222.3 |
| Hospitalization Rate: Lower Confidence Limit | 78.5 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at NEW Britain General Hospital were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 24.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 34.2 |
| Readmission Rate: Lower Confidence Limit | 16.3 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at NEW Britain General Hospital get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .41 (Better than Expected) |
| SIR: Upper Confidence Limit | 1 |
| SIR: Lower Confidence Limit | .13 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether NEW Britain General Hospital's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 81 |
| Transfusion Rate in facility | 17.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 50.4 |
| Transfusion Rate: Lower Confidence Limit | 6.8 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at NEW Britain General Hospital lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 538 |
| Mortality Rate in facility | 15.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 19.4 |
| Mortality Rate: Lower Confidence Limit | 12.7 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago
NEW Britain General Hospital Location: Dialysis Unit, New Britain, Connecticut, 06050 Phone: (860) 224-5195 |
Herald Square Dialysis Llc Location: One Herald Square, New Britain, Connecticut, 06051 Phone: (860) 223-4963 |
News Archive
PAREXEL International Corporation today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Anyone with diabetes who takes blood sugar medication knows their doctor prescribed it to help them. After all, the long-term effects of elevated blood sugar can harm everything from the heart and kidneys to the eyes and feet.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
› Verified 6 days ago